Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_assertion type Assertion NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_head.
- NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_assertion wasGeneratedBy ECO_0000203 NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_provenance.
- NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_assertion wasDerivedFrom befree-20150227 NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_provenance.
- NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_assertion SIO_000772 23296368 NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_provenance.
- NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_assertion evidence source_evidence_literature NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_provenance.
- NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_assertion description "[The latter should be further classified and named by their defective protein or the historical name as follows: i) defective phospholipid remodelling (TAZ defect or Barth syndrome, SERAC1 defect or MEGDEL syndrome) and ii) mitochondrial membrane associated disorders (OPA3 defect or Costeff syndrome, DNAJC19 defect or DCMA syndrome, TMEM70 defect).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948382.RA92TNib3CFrC7NOszGeq65pYsUw-WReNo6bPw2C3fc_I130_provenance.